Mohanraj Gopikrishnan

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Escherichia Coli

Microbial Community

Mild Cognitive Impairment

Top Venues

Journal of cellular biochemistry

Metabolic brain disease

This page only lists publications with an associated author ORCID identifier.

Publications

Sudharsana Sundarrajan, Arthi Venkatesan, Udhaya Kumar S, Mohanraj Gopikrishnan, Iftikhar Aslam Tayubi, Aditya M, Gowrishankar Bychapur Siddaiah, George Priya Doss C, Hatem Zayed
Exome sequence analysis of rare frequency variants in Late-Onset Alzheimer Disease. Metabolic brain disease (2023)
Karthik Sekaran, Rinku Polachirakkal Varghese, Mohanraj Gopikrishnan, Alsamman Mahmoud Alsamman, Achraf El Allali, Hatem Zayed, George Priya Doss C
Unraveling the Dysbiosis of Vaginal Microbiome to Understand Cervical Cancer Disease Etiology-An Explainable AI Approach. Genes 14 (4) (2023)
Karthik Sekaran, Rinku Polachirakkal Varghese, Mohanraj Gopikrishnan, Alsamman Mahmoud Alsamman, Achraf El Allali, Hatem Zayed, George Priya Doss C
Unraveling the Dysbiosis of Vaginal Microbiome to Understand Cervical Cancer Disease Etiology-An Explainable AI Approach. Genes 14 (4) (2023)
Karthik Sekaran, Rinku Polachirakkal Varghese, Mohanraj Gopikrishnan, Alsamman Mahmoud Alsamman, Achraf El Allali, Hatem Zayed, George Priya Doss C
Unraveling the Dysbiosis of Vaginal Microbiome to Understand Cervical Cancer Disease Etiology-An Explainable AI Approach. Genes 14 (4) (2023)
Karthik Sekaran, Rinku Polachirakkal Varghese, Mohanraj Gopikrishnan, Alsamman Mahmoud Alsamman, Achraf El Allali, Hatem Zayed, George Priya Doss C
Unraveling the Dysbiosis of Vaginal Microbiome to Understand Cervical Cancer Disease Etiology-An Explainable AI Approach. Genes 14 (4) (2023)
Mohanraj Gopikrishnan, Sriroopreddy Ramireddy, Rinku Polachirakkal Varghese, Yamuna Devi Bakathavatchalam, Thirumal Kumar D, Abi Manesh, Kamini Walia, Veeraraghavan Balaji, George Priya Doss C
Determination of potential combination of non-β-lactam, β-lactam, and β-lactamase inhibitors/β-lactam enhancer against class D oxacillinases producing Acinetobacter baumannii: Evidence from in-vitro, molecular docking and dynamics simulation. Journal of cellular biochemistry (2023)